Evonik Industries AG (ETR:EVK)

Germany flag Germany · Delayed Price · Currency is EUR
16.83
-0.11 (-0.65%)
Aug 27, 2025, 1:40 PM CET
-0.65%
Market Cap7.89B
Revenue (ttm)14.71B
Net Income (ttm)424.00M
Shares Out466.00M
EPS (ttm)0.92
PE Ratio18.51
Forward PE13.46
Dividend1.17 (6.87%)
Ex-Dividend DateMay 29, 2025
Volume250,231
Average Volume1,086,976
Open16.91
Previous Close16.94
Day's Range16.78 - 17.02
52-Week Range16.13 - 22.39
Beta0.94
RSI46.31
Earnings DateAug 1, 2025

About Evonik Industries AG

Evonik Industries AG produces and sells specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, and Technology & Infrastructure segments. The Specialty Additives segment offers additives for polyurethane foams; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depr... [Read more]

Sector Materials
Founded 1847
Employees 30,669
Stock Exchange Deutsche Börse Xetra
Ticker Symbol EVK
Full Company Profile

Financial Performance

Financial Statements

News

EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 05.08.2025 / 10:16 CET/CEST The issuer is solely responsi...

22 days ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Thomas Wessel, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 05.08.2025 / 10:09 CET/CEST The issuer is solely responsi...

22 days ago - Wallstreet:Online

EQS-PVR: Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Evonik Industries AG Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide ...

23 days ago - Wallstreet:Online

Evonik Industries reports Q2 results

25 days ago - Seeking Alpha

EQS-PVR: Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Evonik Industries AG Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide ...

7 weeks ago - Wallstreet:Online

EQS-AFR: Evonik Industries AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Evonik Industries AG / Preliminary announcement on the disclosure of financial statements Evonik Industries AG: Preliminary announcement of the publicat...

2 months ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Christian Kullmann, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 04.06.2025 / 11:18 CET/CEST The issuer is solely responsi...

3 months ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 03.06.2025 / 10:46 CET/CEST The issuer is solely responsi...

3 months ago - Wallstreet:Online

Evonik Industries AG (EVKIF) Q1 2025 Earnings Call Transcript

Evonik Industries AG (OTCPK:EVKIF) Q1 2025 Results Conference Call May 12, 2025 5:00 AM ETCompany ParticipantsChristian Kullmann - Chairman of the Executive...

3 months ago - Seeking Alpha

Evonik Industries reports Q1 results

3 months ago - Seeking Alpha

Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development

Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven can...

9 months ago - Benzinga

EQS-News: Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery

EQS-News: leon-nanodrugs GmbH / Key word(s): Study results Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery 05.12....

9 months ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Dr. Cornelius Baur, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 26.11.2024 / 10:25 CET/CEST The issuer is solely responsi...

9 months ago - Wallstreet:Online

Evonik Industries reports Q3 results

10 months ago - Seeking Alpha

Agilis Unveils 'Alchemist' AI Solutions to Transform Customer Engagement in the Chemical Industry, with Evonik as Pilot Customer

Newark, New Jersey--(Newsfile Corp. - September 17, 2024) - Agilis, a leader in digital customer engagement solutions for the chemical industry, today announces the launch of Alchemist, a suite of AI-...

1 year ago - Wallstreet:Online